Acasti Pharma, Inc. - stock earnings
ACST Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -1.8 million USD | ? USD |
| 2023Q3 | -2.7 million USD | ? USD |
| 2023Q2 | -3.0 million USD | ? USD |
| 2023Q1 | -21.5 million USD | -23652 USD |
| 2022Q4 | -2.9 million USD | ? USD |
| 2022Q3 | -3.6 million USD | ? USD |
| 2022Q2 | -3.5 million USD | 24818 USD |
| 2022Q1 | -3.2 million USD | 10384 USD |
| 2021Q4 | -3.0 million USD | ? USD |
| 2021Q3 | 773698 USD | ? USD |
| 2021Q2 | -2.5 million USD | 92784 USD |
| 2021Q1 | -4.5 million USD | 91560 USD |
| 2020Q4 | -2.5 million USD | 63628 USD |
| 2020Q3 | -4.6 million USD | ? USD |
| 2020Q2 | -3.4 million USD | ? USD |
| 2020Q1 | 12.1 million USD | ? USD |
| 2019Q4 | -9.2 million USD | ? USD |
| 2019Q3 | -16.2 million USD | ? USD |
| 2019Q2 | -6.8 million USD | ? USD |
| 2019Q1 | -9.8 million USD | ? USD |
| 2018Q4 | -2.5 million USD | ? USD |
| 2018Q3 | -13.5 million USD | ? USD |
| 2018Q2 | -4.3 million USD | ? USD |
| 2018Q1 | -4.7 million USD | ? USD |
| 2017Q4 | -3.8 million USD | ? USD |
| 2017Q3 | -2.9 million USD | ? USD |
| 2017Q2 | -1.6 million USD | ? USD |
| 2017Q1 | -2.7 million USD | ? USD |
| 2016Q4 | -3.0 million USD | ? USD |
| 2016Q3 | -1.4 million USD | 712 USD |
| 2016Q2 | -1.4 million USD | 2157 USD |
| 2016Q1 | -1.1 million USD | 11486 USD |
| 2015Q4 | -989314 USD | 10743 USD |
| 2015Q3 | -1.2 million USD | 2828 USD |
| 2015Q2 | -755304 USD | 4261 USD |
| 2015Q1 | -1.5 million USD | 107011 USD |
| 2014Q4 | -1.6 million USD | 116860 USD |
| 2014Q3 | 2.4 million USD | 22544 USD |
| 2014Q2 | -3.2 million USD | 6501 USD |
| 2014Q1 | -1.7 million USD | 150928 USD |
| 2013Q4 | -1.8 million USD | 156701 USD |
| 2013Q3 | -3.5 million USD | 25896 USD |
| 2013Q2 | -2.9 million USD | 241040 USD |
| 2013Q1 | -1.9 million USD | 6101 USD |
| 2012Q4 | -1.8 million USD | 27739 USD |
| 2012Q3 | -1.7 million USD | 435559 USD |
| 2012Q2 | -1.7 million USD | 231260 USD |
| 2012Q1 | -1.5 million USD | 13303 USD |
| 2011Q4 | -1.7 million USD | 14517 USD |
| 2011Q3 | -2.1 million USD | 31214 USD |
| 2011Q2 | -1.8 million USD | 34839 USD |
| 2011Q1 | -1.1 million USD | 87434 USD |
| 2010Q4 | -1.0 million USD | 29051 USD |
| 2010Q3 | -571175 USD | ? USD |
| 2010Q2 | -437671 USD | ? USD |
| 2010Q1 | -329370 USD | ? USD |
| 2009Q4 | -381054 USD | ? USD |
| 2009Q3 | -353652 USD | ? USD |
| 2009Q2 | -369978 USD | ? USD |
| 2009Q1 | -219538 USD | ? USD |
| 2008Q3 | -177580 USD | ? USD |
ACST Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -31.4 million USD | ? USD |
| 2022 | -7.8 million USD | 10384 USD |
| 2021 | -15.7 million USD | 156050 USD |
| 2020 | -18.2 million USD | ? USD |
| 2019 | -32.7 million USD | ? USD |
| 2018 | -13.1 million USD | ? USD |
| 2017 | -6.0 million USD | ? USD |
| 2016 | -3.6 million USD | 21415 USD |
| 2015 | -1.0 million USD | 170692 USD |
| 2014 | -9.4 million USD | 407437 USD |
| 2013 | -6.6 million USD | 696364 USD |
| 2012 | -6.6 million USD | 127593 USD |
| 2011 | -2.5 million USD | 29891 USD |
| 2010 | -1.5 million USD | ? USD |
ACST
Price: $2.96
52 week price:
Payout Ratio Range:
Earnings Per Share: -5.68 USD
P/E Ratio: -0.41
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 172300
Ebitda: -8.8 millionMarket Capitalization: 32.0 million